Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AMAM will rise by +0.37% over the next 2 Weeks and hit $28.10 by Wednesday, March 20, 2024. In that time frame, AMAM's share price is expected to range between $26.36 and $29.93.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 20, 2024 | 26.33 | 28.10 | 29.79 |
| Mar 19, 2024 | 26.58 | 28.08 | 29.52 |
| Mar 18, 2024 | 26.88 | 28.09 | 29.29 |
| Mar 15, 2024 | 27.09 | 28.07 | 29.06 |
| Mar 14, 2024 | 27.27 | 28.06 | 28.84 |
| Mar 13, 2024 | 27.44 | 28.05 | 28.64 |
| Mar 12, 2024 | 27.61 | 28.03 | 28.44 |
| Mar 11, 2024 | 27.75 | 28.04 | 28.28 |
| Mar 8, 2024 | 27.89 | 28.02 | 28.15 |
| Mar 7, 2024 | 27.96 | 28.00 | 28.04 |
AMAM shares rose +0.07% in Wednesday, March 6, 2024's trading session, rising from a previous close of $27.98 to move at $28.00. The stock demonstrated notable intraday movement (see AMAM's key stats for a full breakdown), fluctuating between $27.98 and $28.00, a +0.07% trading range. While recent weeks have seen some volatility, AMAM has managed to secure a +0.25% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.42M shares changing hands, 405.37K more than the previous session. This amounted to $39.83M in total market activity.
Will AMAM Continue Its Upward Trend?
According to analyst ratings and projections for AMAM, Ambrx Biopharma Inc. shares are anticipated to increase by +6.01%, potentially reaching $29.79 per share by March 20, 2024. Short-term technical indicators currently suggest a neutral sentiment for AMAM. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the AMAM stock forecast, now is a good time to buy AMAM stock because its current trading price is -0.36% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on AMAM covering social and institutional perspectives.
AMAM Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AMAM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 80.28% to 82.20%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 71.14%, indicates significant medium-term strength. However, the 100-day RSI, at 64.23%, points to growing bullish momentum over the long term. Insights into AMAM's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Ambrx Biopharma Inc. Monthly Forecast 2024–2025
September 2024
According to our latest forecast models, Ambrx Biopharma Inc. (AMAM) is positioned to show a strong performance in September 2024. The price is predicted to move between $60.56 and $68.38, settling at an average of $64.92. This could translate to a +131.86% gain.
October 2024
Based on current market signals, Ambrx Biopharma Inc. is projected to trend october 2024. We forecast a trading range from $63.96 to $77.11, with a likely average price of $70.60. Investors could expect a potential return of +152.14%.
November 2024
Our predictive algorithms indicate Ambrx Biopharma Inc. stock may see a shift in November 2024. The expected range spans $72.29–$81.21, with an average target of $77.40. This represents a positive outlook and a possible gain of +176.43%.
December 2024
Analyzing established trends, Ambrx Biopharma Inc. looks set to move in December 2024. Projections place the stock between $76.32 and $86.51, averaging around $81.16. This suggests a +189.86% gain from current levels.
January 2025
Market indicators suggest Ambrx Biopharma Inc. could experience notable changes during January 2025. Prices could fluctuate within $81.47 to $92.49, with a midpoint forecast of $86.58. The stock might deliver a +209.21% gain.
February 2025
Forecasting for February 2025, models estimate that Ambrx Biopharma Inc. may undergo key fluctuations. If trends hold, the stock might trade between $86.21 and $96.05, averaging $91.17. This signals a positive trajectory with potential returns around +225.61%.
March 2025
According to our latest forecast models, Ambrx Biopharma Inc. (AMAM) is positioned to show a strong performance in March 2025. The price is predicted to move between $91.69 and $98.66, settling at an average of $94.99. This could translate to a +239.25% gain.
AMAM's history of dividends and stock splits also plays a role in long-term investor confidence.